(Q83095982)

English

Evaluation of the HER2/neu-derived peptide GP2 for use in a peptide-based breast cancer vaccine trial

scientific article published on 01 June 2006

Statements

Evaluation of the HER2/neu-derived peptide GP2 for use in a peptide-based breast cancer vaccine trial (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit